Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni

PLoS Negl Trop Dis. 2021 May 25;15(5):e0009444. doi: 10.1371/journal.pntd.0009444. eCollection 2021 May.

Abstract

Background: World Health Organization (WHO) guidelines for measuring global progress in schistosomiasis control classify individuals with Schistosoma spp. infections based on the concentration of excreted eggs. We assessed the associations between WHO infection intensity categories and morbidity prevalence for selected S. haematobium and S. mansoni morbidities in school-age children.

Methodology: A total of 22,488 children aged 6-15 years from monitoring and evaluation cohorts in Burkina Faso, Mali, Niger, Uganda, Tanzania, and Zambia from 2003-2008 were analyzed using Bayesian logistic regression. Models were utilized to evaluate associations between intensity categories and the prevalence of any urinary bladder lesion, any upper urinary tract lesion, microhematuria, and pain while urinating (for S. haematobium) and irregular hepatic ultrasound image pattern (C-F), enlarged portal vein, laboratory-confirmed diarrhea, and self-reported diarrhea (for S. mansoni) across participants with infection and morbidity data.

Principal findings: S. haematobium infection intensity categories possessed consistent morbidity prevalence across surveys for multiple morbidities and participants with light infections had elevated morbidity levels, compared to negative participants. Conversely, S. mansoni infection intensity categories lacked association with prevalence of the morbidity measures assessed.

Conclusions/significance: Current status infection intensity categories for S. haematobium were associated with morbidity levels in school-age children, suggesting urogenital schistosomiasis morbidity can be predicted by an individual's intensity category. Conversely, S. mansoni infection intensity categories were not consistently indicative of childhood morbidity at baseline or during the first two years of a preventive chemotherapy control program.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Africa South of the Sahara / epidemiology
  • Animals
  • Chemoprevention
  • Child
  • Diarrhea
  • Female
  • Humans
  • Liver / parasitology*
  • Liver / pathology
  • Male
  • Morbidity
  • Parasite Egg Count
  • Schistosoma haematobium
  • Schistosoma mansoni
  • Schistosomiasis haematobia / pathology*
  • Schistosomiasis mansoni / drug therapy
  • Schistosomiasis mansoni / pathology*
  • Urinary Tract / parasitology*
  • Urinary Tract / pathology

Grants and funding

The Schistosomiasis Control Initiative (now the SCI Foundation) was supported by the Bill and Melinda Gates Foundation (grant 13122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.